SuperworthGE HealthCare Technologies Inc. GEHC
Medical - Devices, Healthcare
$64.67
−0.15%
- Market cap
- $29.2B
- PE
- 18.7×
- 10y median 19.9×
- Forward PE
- Price to sales
- 1.4×
- EV/EBIT
- 13.6×
- Revenue, 12 months
- $21.3B
- +7% on a year ago
- Net margin
- 9.3%
- Free cash flow yield
- 5.4%
GE HealthCare Technologies trades at 18.7× trailing earnings, cheaper than 65% of the last ten years. Revenue was $21.3B over the last twelve months, up 7% on a year earlier with a 9% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $5.2B | $4.7B | $4.8B | $4.9B | $5.3B+2% | $4.8B+3% | $5B+4% | $5.1B+6% | $5.7B+7% | $5.1B+7% | $5.3B+6% | |
| Cost of revenue | $3B | $2.7B | $2.8B | $2.8B | $3B−0% | $2.8B+1% | $3B+7% | $3.2B+11% | $2.1B−30% | $3.2B+14% | $3.1B+3% |
| Gross profit | $2.2B | $1.9B | $2B | $2B | $2.3B+6% | $2B+6% | $2B−1% | $2B−2% | $2.3B−1% | $2B−2% | $2.2B+10% |
| R&D | $315M | $324M | $327M | $316M | $344M+9% | $344M+6% | $302M−8% | $292M−8% | $323M−6% | $345M+0% | $323M+7% |
| SG&A | $1.2B | $1B | $1.1B | $1B | $1.1B−2% | $1B+0% | $1B−4% | $1B+1% | $1.1B−2% | $1.1B+7% | $1.1B+9% |
| $689M | $540M | $608M | $676M | $801M+16% | $629M+17% | $654M+8% | $653M−3% | $827M+3% | $515M−18% | $739M+13% | |
| Interest expense | $131M | $138M | $131M | $130M | $111M−15% | $111M−20% | $113M−14% | $123M−5% | $103M−7% | $96M−14% | $114M+1% |
| Pre-tax income | $609M | $512M | $578M | $658M | $834M+37% | $692M+35% | $613M+6% | $643M−2% | $821M−2% | $505M−27% | $693M+13% |
| $193M | $124M | $143M | $168M | $96M−50% | $104M−16% | $113M−21% | $179M+7% | $219M+128% | $94M−10% | $119M+5% | |
| Net income | $403M | $374M | $428M | $470M | $721M+79% | $564M+51% | $486M+14% | $446M−5% | $589M−18% | $389M−31% | $561M+15% |
| $0.88 | $0.81 | $0.93 | $1.02 | $1.57+78% | $1.23+52% | $1.06+14% | $0.98−4% | $0.38−76% | $0.85−31% | $1.24+17% | |
| 458M | 459M | 459M | 459M | 459M+0% | 459M+0% | 458M−0% | 457M−0% | 460.3M+0% | 457M−0% | 454M−1% |
From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.
Estimates
Next earnings report: .
Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.
Peers
Companies in Medical - Devices within ten times GE HealthCare Technologies's size, closest in size first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| GEHCGE HealthCare Technologies Inc. | $29.2B | 18.7× | 19.9× | 1.4× | +7% | 9.3% | |
| DXCMDexCom, Inc. | $31.8B | 33.3× | 142× | 6.4× | +16% | 20.1% | |
| EWEdwards Lifesciences Corporation | $49.4B | 49.3× | 40.5× | 7.6× | +15% | 15.4% | |
| BSXBoston Scientific Corporation | $60.3B | 16.8× | 66.3× | 2.9× | +14% | 17.5% | |
| SYKStryker Corporation | $105.6B | 28.5× | 41.2× | 4.1× | +8% | 14.4% | |
| MDTMedtronic plc | $109.4B | 21.1× | 28.4× | 2.9× | +10% | 13.9% | |
| ABTAbbott Laboratories | $170.8B | 31.8× | 36.2× | 3.7× | +8% | 11.6% | |
| Peer median | $82.9B | 30.2× | 40.8× | 3.9× | +12% | 14.9% |
About
- Industry
- Medical - Devices
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .